Ideal prognostic model in lung squamous cell carcinoma.
作者信息
Kinoshita Tomonari
机构信息
Department of Thoracic Surgery, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
出版信息
Transl Lung Cancer Res. 2020 Jun;9(3):430-431. doi: 10.21037/tlcr.2020.03.22.
Abstract
摘要
相似文献
1
Ideal prognostic model in lung squamous cell carcinoma.肺鳞状细胞癌的理想预后模型。
Transl Lung Cancer Res. 2020 Jun;9(3):430-431. doi: 10.21037/tlcr.2020.03.22.
2
A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.一种新的 12 基因标志物可作为 IA 期和 IB 期肺鳞癌患者的独立预后模型。
Clin Transl Oncol. 2021 Nov;23(11):2368-2381. doi: 10.1007/s12094-021-02638-1. Epub 2021 May 24.
3
[Prognostic factor analysis of patients with unresectablelung squamous cell carcinoma].[不可切除肺鳞状细胞癌患者的预后因素分析]
Zhonghua Zhong Liu Za Zhi. 2021 May 23;43(5):569-573. doi: 10.3760/cma.j.cn112152-20191126-00763.
4
Survival-associated N-adenosine methyltransferase signatures in lung squamous cell carcinoma and clinical verification.肺鳞癌中与生存相关的 N-腺苷甲基转移酶特征及其临床验证。
BMC Cancer. 2021 Nov 24;21(1):1265. doi: 10.1186/s12885-021-08939-6.
5
The clinical and prognostic value of polo-like kinase 1 in lung squamous cell carcinoma patients: immunohistochemical analysis.肺鳞状细胞癌患者中polo样激酶1的临床及预后价值：免疫组化分析
Biosci Rep. 2017 Aug 31;37(4). doi: 10.1042/BSR20170852. Epub 2017 Jul 19.
6
Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis.三种肺鳞癌组织学亚型的生存比较：基于人群的倾向评分匹配分析。
Lung Cancer. 2020 Apr;142:13-19. doi: 10.1016/j.lungcan.2020.01.020. Epub 2020 Feb 3.
7
8
A prognostic 4-lncRNA expression signature for lung squamous cell carcinoma.用于肺鳞癌的预后 4 个长链非编码 RNA 表达特征。
Artif Cells Nanomed Biotechnol. 2018 Sep;46(6):1207-1214. doi: 10.1080/21691401.2017.1366334. Epub 2017 Aug 24.
9
Construction of a prognostic model for lung squamous cell carcinoma based on seven N6-methylandenosine-related autophagy genes.基于七个 N6-甲基腺苷相关自噬基因构建肺鳞状细胞癌预后模型。
Math Biosci Eng. 2021 Aug 9;18(5):6709-6723. doi: 10.3934/mbe.2021333.
10
miR-448 is a novel prognostic factor of lung squamous cell carcinoma and regulates cells growth and metastasis by targeting DCLK1.miR-448 是肺鳞癌的一个新的预后因素，通过靶向 DCLK1 调节细胞的生长和转移。
Biomed Pharmacother. 2017 May;89:1227-1234. doi: 10.1016/j.biopha.2017.02.017. Epub 2017 Mar 17.
引用本文的文献
1
Identification of and expression as novel candidate biomarkers for predicting the benefit of immunotherapy in lung squamous cell carcinoma.鉴定并表达作为预测肺鳞状细胞癌免疫治疗获益的新型候选生物标志物。
Ann Transl Med. 2021 Jul;9(13):1081. doi: 10.21037/atm-21-2186.
本文引用的文献
1
Prognostic model based on circular RNA circPDK1 for resected lung squamous cell carcinoma.基于环状RNA circPDK1的肺鳞状细胞癌切除术后预后模型
Transl Lung Cancer Res. 2019 Dec;8(6):907-919. doi: 10.21037/tlcr.2019.11.20.
2
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020.NCCN 指南解读：非小细胞肺癌，第 1.2020 版。
J Natl Compr Canc Netw. 2019 Dec;17(12):1464-1472. doi: 10.6004/jnccn.2019.0059.
3
Predictive value of a prognostic model based on pathologic features in lung invasive adenocarcinoma.基于病理特征的肺浸润性腺癌预后模型的预测价值。
Lung Cancer. 2019 May;131:14-22. doi: 10.1016/j.lungcan.2019.03.002. Epub 2019 Mar 4.
4
Increased CYFRA 21-1, CEA and NSE are Prognostic of Poor Outcome for Locally Advanced Squamous Cell Carcinoma in Lung: A Nomogram and Recursive Partitioning Risk Stratification Analysis.CYFRA 21-1、癌胚抗原（CEA）和神经元特异性烯醇化酶（NSE）升高提示局部晚期肺鳞状细胞癌预后不良：列线图及递归划分风险分层分析
Transl Oncol. 2018 Aug;11(4):999-1006. doi: 10.1016/j.tranon.2018.05.008. Epub 2018 Jun 27.
5
Emerging landscape of circular RNAs in lung cancer.环状 RNA 在肺癌中的研究进展。
Cancer Lett. 2018 Jul 28;427:18-27. doi: 10.1016/j.canlet.2018.04.006. Epub 2018 Apr 11.
6
Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors.基于临床和病理因素的可切除肺鳞癌患者风险分层模型。
J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.
7
Prognostic impact of preoperative tumor marker levels and lymphovascular invasion in pathological stage I adenocarcinoma and squamous cell carcinoma of the lung.术前肿瘤标志物水平和脉管侵犯对病理 I 期肺腺癌和肺鳞癌的预后影响。
J Thorac Oncol. 2015 Apr;10(4):619-28. doi: 10.1097/JTO.0000000000000480.
8
A clinicopathological study of resected small-sized squamous cell carcinomas of the peripheral lung: prognostic significance of serum carcinoembryonic antigen levels.周围型肺小尺寸鳞状细胞癌切除标本的临床病理研究：血清癌胚抗原水平的预后意义
Ann Thorac Cardiovasc Surg. 2013;19(5):351-7. doi: 10.5761/atcs.oa.12.01843. Epub 2012 Dec 13.
9
Cumulative incidence of and predictive factors for lung cancer in IPF.特发性肺纤维化中肺癌的累积发病率和预测因素。
Respirology. 2009 Jul;14(5):723-8. doi: 10.1111/j.1440-1843.2009.01547.x.
10
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.非小细胞肺癌：流行病学、危险因素、治疗及生存情况。
Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584.
Zotero 插件